Nanoform Finland PLC (FRA:4YL)

Q1 2025 Nanoform Finland Oyj Earnings Call Transcript

May 20, 2025 / 11:00 AM GMT

Release Date Price: €0.961 (+3.67%)

Transcript

Key Points

Positve

Nanoform Finland PLC (STU:4YL) has seen a significant increase in the number of projects signed, with 11 new projects year-to-date.
The company has successfully signed term sheets for its nano and salutamide project in major markets such as Germany, France, Japan, and the US.
Nanoform Finland PLC (STU:4YL) has a strong financial position with a cash balance of over 37 million euros and no debt, providing more than two years of runway.
The company has received a new patent in the United States for its CPens technology, enhancing its intellectual property portfolio.
Nanoform Finland PLC (STU:4YL) has expanded its customer base, now working with 12 of the top 20 pharma companies globally.

Negative

Despite the growth, the company is still experiencing a cash burn, although it has decreased compared to previous years.
The company faces challenges in managing a large portfolio of country-specific partnerships, which can be resource-intensive.
There is uncertainty regarding the long-term booking of exclusivity fees and other operating income.
The company has not yet provided specific revenue projections for its nano and salutamide project, leading to some uncertainty about its financial impact.
The transition from IV to subcutaneous delivery for biologics, while promising, is still in the early stages and may face regulatory and market adoption challenges.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

NANOFH.HE - Nanoform Finland Oyj
Q1 2025 Nanoform Finland Oyj Earnings Call
May 20, 2025 / 11:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Welcome to the conference call. For the first part of the conference call, the participants will be in listen-only mode. During the questions and answer session, participants are able to ask questions by dialing 5 on their telephone keypad. Now I will hand a conference over to the speakers. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Good afternoon all and a warm welcome to Nanoform's first quarter 2025 report presentation.

My name is Henry von Hartmann, and I'm your director of investor relations.

Today our CEO Edward Ekstram, CFO Albert

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.